Yakult Honsha Co.,Ltd. (YKLTY)
Yakult Honsha Co.,Ltd. operates in the Beverages - Non-Alcoholic industry of the Consumer Defensive sector, headquartered in Tokyo, TY, JP. The stock last traded at $8.65, up 0.00% on the session, giving a market capitalisation of $4.98B. On trailing twelve-month figures it carries a trailing P/E of 18.20, a net margin of 9.4%. Its beta of 0.08 implies it has historically moved less than the broad market.
Founded in Tokyo, Japan, in 1935, Yakult Honsha Co., Ltd. is a diversified corporation engaged in the creation and sale of a broad spectrum of goods. Its principal activities span food and beverage items, beauty products, and pharmaceutical drugs. The company's extensive food and beverage division operates across several global territories, including Japan, the Americas, Asia and Oceania, and Europe. This segment provides various offerings such as fermented milk beverages, juices, and noodles, which are distributed to consumers through both direct-to-home delivery services and conventional retail outlets. Within its pharmaceutical operations, Yakult Honsha focuses on developing and commercializing specialized medicines. These include the anti-cancer medication Elplat, along with generic versions of anti-tumor agents like Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Beyond these core areas, Yakult Honsha also participates in the cosmetics sector and notably owns a professional sports franchise, the Tokyo Yakult Swallows baseball team.
Yakult Honsha Co.,Ltd. is most often compared with the following Consumer Defensive names: